Pretransplant diabetes had no prognostic influence on first biopsy-proven acute rejection and death-censored graft failure hazard rates , nor on eGFR , but was associated with significantly higher rates of death with a functioning graft ( DWFG ) ( p = 0.003 ) , DWFG due to a cardiovascular event ( p = 0.005 ) and infection that required hospitalisation ( p = 0.03 ) .